CEO of MSD Korea elected as KRPIA chairman.

Published: 2005-06-17 06:59:00

Updated: 2005-06-17 06:59:00

The Korea Multinationala Drug Corporation group, KRPIA, elected Mr. Mark Timney, the CEO of MSD Korea as the 7th chairman of KRPIA on June 14 succeeding Mr. Michael Richter who led the group during the past 2 years.

Mr.Timney said "I was pleased to accept the directorate's resolution for the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK